Bristol Myers Squibb BMY
NYSE BMY
$63.03 +0.20 (+0.32%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bristol Myers Squibb (BMY) Goodwill & Intangibles (2009 - 2026)

Bristol Myers Squibb's (BMY) quarterly Goodwill & Intangibles came in at $39.1 billion in Q2 2026, down 9.33% year-over-year from $43.2 billion in Q2 2025, and down 2.14% quarter-over-quarter from $40.0 billion in Q1 2026.

Analysis

Bristol Myers Squibb (BMY) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (BMY) has reported Goodwill & Intangibles for 18 consecutive years, with $39.1 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 9.33% year-over-year to $39.1 billion in Q2 2026; TTM through Jun 2026 was $39.1 billion, a 9.33% decrease from a year earlier, with the FY2025 full-year figure at $40.9 billion, down 9.26% from the prior year.
  • Goodwill & Intangibles was $39.1 billion for Q2 2026 at Bristol Myers Squibb, down from $40.0 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $60.6 billion in Q1 2022 and troughed at $39.1 billion in Q2 2026.
  • A 5-year average of $49.4 billion and a median of $49.4 billion in 2023 frame the typical range for Goodwill & Intangibles.
  • Across the five-year window, Goodwill & Intangibles fell 0.43% in 2024 and declined 18.85% in 2025, its largest moves.
  • Over 5 years, Goodwill & Intangibles stood at $57.0 billion in 2022, then fell by 15.38% to $48.2 billion in 2023, then decreased by 6.66% to $45.0 billion in 2024, then decreased by 9.26% to $40.9 billion in 2025, then dropped by 4.23% to $39.1 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $39.1 billion (Q2 2026), $40.0 billion (Q1 2026), and $40.9 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.13 Bn
Mar 31, 2026 39.98 Bn
Dec 31, 2025 40.86 Bn
Sep 30, 2025 42.21 Bn
Jun 30, 2025 43.15 Bn
Mar 31, 2025 44.22 Bn
Dec 31, 2024 45.03 Bn
Sep 30, 2024 48.72 Bn
Jun 30, 2024 51.16 Bn
Mar 31, 2024 54.50 Bn
Dec 31, 2023 48.24 Bn
Sep 30, 2023 50.10 Bn
Jun 30, 2023 52.47 Bn
Mar 31, 2023 54.73 Bn
Dec 31, 2022 57.01 Bn
Sep 30, 2022 59.29 Bn
Jun 30, 2022 58.14 Bn
Mar 31, 2022 60.60 Bn
Dec 31, 2021 63.03 Bn
Sep 30, 2021 65.45 Bn